Nr-axSpA Active Not Recruiting Phase 3 Trials for Certolizumab pegol (DB08904)

IndicationStatusPhase
DBCOND0078160 (Nr-axSpA)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02552212Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of ASTreatment